Desmosomes and disease: pemphigus and bullous impetigo

被引:97
作者
Payne, AS
Hanakawa, Y
Amagai, M
Stanley, JR
机构
[1] Univ Penn, Dept Dermatol, Philadelphia, PA 19104 USA
[2] Ehime Univ, Dept Dermatol, Matsuyama, Ehime 790, Japan
[3] Keio Univ, Sch Med, Dept Dermatol, Shinjuku Ku, Tokyo, Japan
关键词
D O I
10.1016/j.ceb.2004.07.006
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Desmosomal cadherins are the pathophysiologic targets of autoimmune or toxin-mediated disruption in the human diseases pemphigus and bullous impetigo (including its generalized form, called staphylococcal scalded skin syndrome). Experiments exploiting the production of both pathogenic and nonpathogenic antidesmoglein antibodies in pemphigus patients' sera have afforded data that make an invaluable contribution towards identifying the functional domains of the desmogleins involved in intercellular adhesion. Conformational epitopes of antidesmoglein autoantibodies in pemphigus patients' sera and the specific cleavage site of desmoglein 1 by exfoliative toxin have been identified, implicating the N-terminal extracellular domains of the desmogleins as critical regions for controlling intercellular adhesion. Furthermore, the development of active autoimmune mouse models for pemphigus allows in vivo characterization of the disease and its pathogenesis. These studies offer new insight into the potential mechanisms of acantholysis in pemphigus and staphylococcal-associated blistering disease, with implications for the role of desmogleins in desmosomal structure and function.
引用
收藏
页码:536 / 543
页数:8
相关论文
共 65 条
[1]   CONFORMATIONAL EPITOPES OF PEMPHIGUS ANTIGENS (DSG1 AND DSG3) ARE CALCIUM-DEPENDENT AND GLYCOSYLATION INDEPENDENT [J].
AMAGAI, M ;
ISHII, K ;
HASHIMOTO, T ;
GAMOU, S ;
SHIMIZU, N ;
NISHIKAWA, T .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1995, 105 (02) :243-247
[2]   Toxin in bullous impetigo and staphylococcal scalded-skin syndrome targets desmoglein 1 [J].
Amagai, M ;
Matsuyoshi, N ;
Wang, ZH ;
Andl, C ;
Stanley, JR .
NATURE MEDICINE, 2000, 6 (11) :1275-1277
[3]   AUTOANTIBODIES AGAINST A NOVEL EPITHELIAL CADHERIN IN PEMPHIGUS-VULGARIS, A DISEASE OF CELL-ADHESION [J].
AMAGAI, M ;
KLAUSKOVTUN, V ;
STANLEY, JR .
CELL, 1991, 67 (05) :869-877
[4]   ANTIGEN-SPECIFIC IMMUNOADSORPTION OF PATHOGENIC AUTOANTIBODIES IN PEMPHIGUS FOLIACEUS [J].
AMAGAI, M ;
HASHIMOTO, T ;
GREEN, KJ ;
SHIMIZU, N ;
NISHIKAWA, T .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1995, 104 (06) :895-901
[5]   Use of autoantigen-knockout mice in developing an active disease model for pemphigus [J].
Amagai, M ;
Tsunoda, K ;
Suzuki, H ;
Nishifuji, K ;
Koyasu, S ;
Nishikawa, T .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (05) :625-631
[6]   Desmoglein as a target in autoimmunity and infection [J].
Amagai, M .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2003, 48 (02) :244-252
[7]   The clinical phenotype of pemphigus is defined by the anti-desmoglein autoantibody profile [J].
Amagai, M ;
Tsunoda, K ;
Zillikens, D ;
Nagai, T ;
Nishikawa, T .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1999, 40 (02) :167-170
[8]   AUTOANTIBODIES AGAINST THE AMINO-TERMINAL CADHERIN-LIKE BINDING DOMAIN OF PEMPHIGUS-VULGARIS ANTIGEN ARE PATHOGENIC [J].
AMAGAI, M ;
KARPATI, S ;
PRUSSICK, R ;
KLAUSKOVTUN, V ;
STANLEY, JR .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (03) :919-926
[9]   ABSORPTION OF PATHOGENIC AUTOANTIBODIES BY THE EXTRACELLULAR DOMAIN OF PEMPHIGUS-VULGARIS ANTIGEN (DSG3) PRODUCED BY BACULOVIRUS [J].
AMAGAI, M ;
HASHIMOTO, T ;
SHIMIZU, N ;
NISHIKAWA, T .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 94 (01) :59-67
[10]   Staphylococcal exfoliative toxin B specifically cleaves desmoglein 1 [J].
Amagai, M ;
Yamaguchi, T ;
Hanakawa, Y ;
Nishifuji, K ;
Sugai, M ;
Stanley, JR .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2002, 118 (05) :845-850